Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4

Conditions

Neoplasms 15Endometrial Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 5Breast Neoplasms 5Uterine Cervical Neoplasms 4Rectal Neoplasms 4Ovarian Neoplasms 4Head and Neck Neoplasms 4Pancreatic Neoplasms 3Melanoma 3Colonic Neoplasms 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Osteosarcoma 2Locally Advanced Rectal Cancer (LARC) 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Neuroendocrine 2Carcinoma, Hepatocellular 2Carcinoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1

Interventions

pembrolizumab 34Cisplatin 29Paclitaxel 15Brachytherapy 15Radiotherapy 14Carboplatin 14Bevacizumab 14Blood Specimen Collection 13Specimen Handling 12Magnetic Resonance Spectroscopy 11Colposcopy 11Nivolumab 10Drug Therapy 10atezolizumab 8Human Papillomavirus DNA Tests 8Gemcitabine 8lenvatinib 7Radiation 6Platinum 6Biopsy 6toripalimab 5cemiplimab 5Surveys and Questionnaires 5Standard of Care 5Radiotherapy, Intensity-Modulated 5Practice Guidelines as Topic 5Patient Navigation 5Fulvestrant 5Fluorodeoxyglucose F18 5zimberelimab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × dostarlimab × 1 year × Clear all
NCT06023862 2026-05-06

DOVE

Yonsei University

Phase 2 Recruiting
198 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Clear Cell

NCT04068753 2026-02-10

STAR

University of Oklahoma

Phase 2 Active not recruiting
66 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT07336147 2026-01-14

Dostarlimab, Cisplatin and Etoposide in Combination With Radiotherapy in Sandwich Sequence for Small Cell Neuroendocrine Cervical Carcinoma

Chang Gung Memorial Hospital

Phase 2 Recruiting
45 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT06238635 2026-01-13

Dostarlimab and Cobolimab in Advanced Cervical Cancer

Beth Israel Deaconess Medical Center

Phase 2 Active not recruiting
66 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡